EP2981282
GROWTH HORMONE COMPOUND FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.4.2014EP published:
4.11.2020EP application number:
14715022.1
EPO information:
European Patent Register
Max expiry date:
3.4.2034
Title:
GROWTH HORMONE COMPOUND FORMULATION
Timeline
Today
4.4.2014EP application
4.11.2020EP Publication
Owner
Name:
Novo Nordisk Health Care AGAddress:
Thurgauerstrasse 36/38 8050 Zürich, CH
Inventor
Name:
NIELSEN, JetteAddress:
2880 Bagsværd, DK
Name:
ESKLING, MarieAddress:
2880 Bagsværd, DK
Name:
CHRISTENSEN, Stina GranzauAddress:
2880 Bagsværd, DK
Name:
HØJBY, MichaelAddress:
2880 Bagsværd, DK
Name:
OLSEN, Minna BrændholtAddress:
2880 Bagsværd, DK
Priority
Number:
13162480Date:
5.4.2013Country:
EP
Number:
201361821890 PDate:
10.5.2013Country:
US
Number:
13184957Date:
18.9.2013Country:
EP
Number:
201361879956 PDate:
19.9.2013Country:
US
Classification
Categories:
A61K 9/00, A61K 47/10, A61K 47/18, A61K 47/26, A61K 47/54, A61K 38/27, A61P 5/06